Regulus Therapeutics Inc. 3 SEC Filings

Filed On	Filing
12 Jun 2023	Form 3: Klassen Preston, President & Head of R & D No securities owned
27 Jan 2021	Form 3: Huang Alice Shih-hou, Director Holds 25,604 shares of Common Stock
04 Aug 2020	Form 3: Drygin Denis, Chief Scientific Officer No securities owned
08 May 2020	Form 3: Sarissa Capital Master Fund Ii Lp, 10% owner Holds 76,356 shares of Common Stock
03 Sep 2019	Form 3: Calsada Crispina, Chief Financial Officer No securities owned
11 Jun 2019	Form 3: Nunn Jason Raleigh, Director No securities owned
11 Jun 2019	Form 3: Simeonidis Simos, Director Holds 1,851,851 shares of Common Stock
17 May 2019	Form 3: Denner Alexander J, 10% owner and 4 others Holds 1,851,851 shares of Common Stock
02 Jan 2019	Form 3: Aker Christopher Ray, Sr. VP & General Counsel Holds 2,747 shares of Common Stock
17 Jul 2018	Form 3: Chang Carmen, 10% owner Holds 10,989,010 shares of Common Stock
17 Jul 2018	Form 3: Behbahani Ali, 10% owner Holds 10,989,010 shares of Common Stock
17 Apr 2018	Form 3: Collier Kathryn J, Director No securities owned
27 Nov 2017	Form 3: Bvf Partners L P/IL, 10% owner and 6 others Holds 6,140,322 shares of Common Stock, $0.001 par value per share
31 Jul 2017	Form 3: Viswanathan Ravi, 10% owner Holds 10,989,010 shares of Common Stock
31 Jul 2017	Form 3: Sonsini Peter W., 10% owner Holds 10,989,010 shares of Common Stock
31 Jul 2017	Form 3: Sandell Scott D, 10% owner Holds 10,989,010 shares of Common Stock
31 Jul 2017	Form 3: Sakoda Jon, 10% owner Holds 10,989,010 shares of Common Stock
31 Jul 2017	Form 3: Puttagunta Chetan, 10% owner Holds 10,989,010 shares of Common Stock
31 Jul 2017	Form 3: Mott David M, 10% owner Holds 10,989,010 shares of Common Stock
31 Jul 2017	Form 3: Makower Joshua, 10% owner Holds 10,989,010 shares of Common Stock

Comments